CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis

Neurobiology of Disease

Volumn 16, Issue 3, 2004, Pages 630-637

  Duan, Rui Sheng ^a   Chen, Zhiguo ^a   Bao, Lei ^a   Quezada, Hernan Concha ^a   Nennesmo, Inger ^b   Winblad, Bengt ^a   Zhu, Jie ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JILIN UNIVERSITY   (China)

Author keywords

CCR5; Experimental autoimmune neuritis; Guillain Barr syndrome; IP 10; MIP 1

Indexed keywords

ANTIGEN; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGENIC AGENT; PEPTIDE DERIVATIVE;

ARTICLE; AUTOIMMUNE DISEASE; CAUDA EQUINA; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; IMMUNIZATION; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCIATIC NERVE; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; GENE EXPRESSION; GUILLAIN-BARRE SYNDROME; IMMUNIZATION; INTERLEUKIN-10; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYELIN P0 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SCIATIC NERVE; SPLEEN;

EID: 3242697187     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.04.007     Document Type: Article

References (36)

1. Andres P.G., Beck P.L., Mizoguchi E., Mizoguchi A., Bhan A.K., Dawson T., Kuziel W.A., Maeda N., MacDermott R.P., Podolsky D.K., Reinecker H.C. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164:2000;6303-6312
2. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:1994;97-179
3. Bajetto A., Bonavia R., Barbero S., Florio T., Schettini G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22:2001;147-184
4. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:1997;640-644
5. Chen Z., Yu S., Bakhiet M., Winblad B., Zhu J. The chemokine receptor CCR5 is not a necessary inflammatory mediator in kainic acid-induced hippocampal injury: evidence for a compensatory effect by increased CCR2 and CCR3. J. Neurochem. 86:2003;61-68
6. D'Ambrosio D., Panina-Bordignon P., Sinigaglia F. Chemokine receptors in inflammation: an overview. J. Immunol. Methods. 273:2003;3-13
7. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., Patel D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188:1998;1413-1419
8. Fujioka T., Purev E., Rostami A. Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. J. Neuroimmunol. 97:1999;51-59
9. Fujioka T., Purev E., Kremlev S.G., Ventura E.S., Rostami A. Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis. J. Neuroimmunol. 108:2000;181-191
10. Garred P., Madsen H.O., Petersen J., Marquart H., Hansen T.M., Freiesleben Sorensen S., Volck B., Svejgaard A., Andersen V. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J. Rheumatol. 25:1998;1462-1465
11. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2:2001;108-115
12. Godessart N., Kunkel S.L. Chemokines in autoimmune disease. Curr. Opin. Immunol. 13:2001;670-675
13. Gomez-Reino J.J., Pablos J.L., Carreira P.E., Santiago B., Serrano L., Vicario J.L., Balsa A., Figueroa M., de Juan M.D. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 42:1999;989-992
14. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barre syndrome - Part I. Muscle Nerve. 18:1995;137-153
15. Kieseier B.C., Krivacic K., Jung S., Pischel H., Toyka K.V., Ransohoff R.M., Hartung H.P. Sequential expression of chemokines in experimental autoimmune neuritis. J. Neuroimmunol. 110:2000;121-129
16. Kieseier B.C., Tani M., Mahad D., Oka N., Ho T., Woodroofe N., Griffin J.W., Toyka K.V., Ransohoff R.M., Hartung H.P. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain. 125:2002;823-834
17. Kuziel W.A., Dawson T.C., Quinones M., Garavito E., Chenaux G., Ahuja S.S., Reddick R.L., Maeda N. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis. 167:2003;25-32
18. Loetscher P., Uguccioni M., Bordoli L., Baggiolini M., Moser B., Chizzolini C., Dayer J.M. CCR5 is characteristic of Th1 lymphocytes. Nature. 391:1998;344-345
19. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2:2001;102-107
20. Martin K., Heinzlmann M., Borchers R., Mack M., Loeschke K., Folwaczny C. Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clin. Immunol. 98:2001;18-22
21. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:2001;123-128
22. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology, XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52:2000;145-176
23. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:1991;617-648
24. Orlikowski D., Chazaud B., Plonquet A., Poron F., Sharshar T., Maison P., Raphael J.C., Gherardi R.K., Creange A. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis. J. Neuroimmunol. 134:2003;118-127
25. Premack B.A., Schall T.J. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1996;1174-1178
26. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754
27. Raport C.J., Gosling J., Schweickart V.L., Gray P.W., Charo I.F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271:1996;17161-17166
28. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242
29. Samson M., Labbe O., Mollereau C., Vassart G., Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry (Mosc.). 35:1996;3362-3367
30. Schmidt B., Toyka K.V., Kiefer R., Full J., Hartung H.P., Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 19:1996;474-487
31. Schrum S., Probst P., Fleischer B., Zipfel P.F. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J. Immunol. 157:1996;3598-3604
32. Simpson J., Rezaie P., Newcombe J., Cuzner M.L., Male D., Woodroofe M.N. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J. Neuroimmunol. 108:2000;192-200
33. Thelen M. Dancing to the tune of chemokines. Nat. Immunol. 2:2001;129-134
34. Tran E.H., Kuziel W.A., Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. Eur. J. Immunol. 30:2000;1410-1415
35. Zhu J., Bai X.F., Mix E., Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin. Immunol. Immunopathol. 84:1997;85-94
36. Zou L.P., Pelidou S.H., Abbas N., Deretzi G., Mix E., Schaltzbeerg M., Winblad B., Zhu J. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol. 98:1999;168-175